Literature DB >> 22687258

Infiltration of CD40-positive tumor-associated macrophages indicates a favorable prognosis in colorectal cancer patients.

Makoto Kinouchi1, Koh Miura, Takayuki Mizoi, Kazuyuki Ishida, Wataru Fujibuchi, Hiroyuki Sasaki, Shinobu Ohnuma, Kazuya Saito, Yu Katayose, Takeshi Naitoh, Fuyuhiko Motoi, Ken-ichi Shiiba, Shinichi Egawa, Chikashi Shibata, Michiaki Unno.   

Abstract

BACKGROUND/AIMS: Recently the role of tumor-associated macrophages (TAMs) on immunity has been variously discussed. We studied a series of cell surface antigens in TAMs in colorectal cancer tissues and their corresponding normal tissues using flow cytometry to find out prognostic indicators of these patients.
METHODOLOGY: We assessed the numbers of CD14+ macrophages positive for each of the cell surface antigens (CD80, CD86, HLA-DR, CD1a, CD40 and CD83) in cancer tissues and corresponding normal tissues among 31 patients with colorectal cancer, and performed the univariate and multivariate analysis to find out prognostic indicators for overall survival among the patients.
RESULTS: The numbers of CD80+, CD86+ and HLA-DR+ TAMs in the cancer tissues were higher than those in corresponding normal tissues. Inversely CD40+ and CD83+ macrophages in cancer tissues were less than those in normal tissues. With the multivariate analysis, the number of CD40+ TAMs, as well as lymph node metastasis and distant metastasis, was shown to be an independent prognostic factor of colorectal cancer patients.
CONCLUSIONS: The dense infiltration of CD40+ TAM in colorectal cancer tissues indicates a favorable prognosis, which suggests that CD40 plays an important role in the tumor immunity of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22687258     DOI: 10.5754/hge12372

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  19 in total

1.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 2.  Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.

Authors:  Umar Mehraj; Hina Qayoom; Manzoor A Mir
Journal:  Breast Cancer       Date:  2021-03-04       Impact factor: 4.239

3.  Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression.

Authors:  Changbin Zhu; Dana Mustafa; Ping-Pin Zheng; Marcel van der Weiden; Andrea Sacchetti; Maarten Brandt; Ihsan Chrifi; Dennie Tempel; Pieter J M Leenen; Dirk Jan Duncker; Caroline Cheng; Johan M Kros
Journal:  Neuro Oncol       Date:  2017-05-01       Impact factor: 12.300

4.  CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

Authors:  Jonathan M Weiss; W Gregory Alvord; Octavio A Quiñones; Jimmy K Stauffer; Robert H Wiltrout
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

Review 5.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

6.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

7.  Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer.

Authors:  G J K Guthrie; C S D Roxburgh; C H Richards; P G Horgan; D C McMillan
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

Review 8.  Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues.

Authors:  Eva Van Overmeire; Damya Laoui; Jiri Keirsse; Jo A Van Ginderachter; Adelaida Sarukhan
Journal:  Front Immunol       Date:  2014-03-26       Impact factor: 7.561

9.  Jacalin-Activated Macrophages Exhibit an Antitumor Phenotype.

Authors:  Cláudia Danella Polli; Luciana Pereira Ruas; Luciana Chain Veronez; Thais Herrero Geraldino; Fabiana Rossetto de Morais; Maria Cristina Roque-Barreira; Gabriela Pereira-da-Silva
Journal:  Biomed Res Int       Date:  2016-03-29       Impact factor: 3.411

10.  Colorectal cancer-derived microvesicles modulate differentiation of human monocytes to macrophages.

Authors:  Monika Baj-Krzyworzeka; Bożenna Mytar; Rafał Szatanek; Marcin Surmiak; Kazimierz Węglarczyk; Jarek Baran; Maciej Siedlar
Journal:  J Transl Med       Date:  2016-02-02       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.